Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Interaction of SIGNR1 expressed by marginal zone macrophages with marginal zone B cells is essential to early IgM responses against Streptococcus pneumoniae.

Koppel EA, Litjens M, van den Berg VC, van Kooyk Y, Geijtenbeek TB.

Mol Immunol. 2008 May;45(10):2881-7. doi: 10.1016/j.molimm.2008.01.032. Epub 2008 Mar 17.

PMID:
18343501
2.

Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis.

Wieland CW, Koppel EA, den Dunnen J, Florquin S, McKenzie AN, van Kooyk Y, van der Poll T, Geijtenbeek TB.

Microbes Infect. 2007 Feb;9(2):134-41. Epub 2006 Dec 14.

PMID:
17224292
3.

DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14.

Koppel EA, Saeland E, de Cooker DJ, van Kooyk Y, Geijtenbeek TB.

Immunobiology. 2005;210(2-4):203-10.

PMID:
16164027
4.

Carbohydrate specificities of the murine DC-SIGN homologue mSIGNR1.

Koppel EA, Ludwig IS, Appelmelk BJ, van Kooyk Y, Geijtenbeek TB.

Immunobiology. 2005;210(2-4):195-201.

PMID:
16164026
5.

Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection.

Koppel EA, Wieland CW, van den Berg VC, Litjens M, Florquin S, van Kooyk Y, van der Poll T, Geijtenbeek TB.

Eur J Immunol. 2005 Oct;35(10):2962-9.

6.

Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation.

Koppel EA, van Gisbergen KP, Geijtenbeek TB, van Kooyk Y.

Cell Microbiol. 2005 Feb;7(2):157-65. Review.

PMID:
15659060
7.

Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1.

Koppel EA, Ludwig IS, Hernandez MS, Lowary TL, Gadikota RR, Tuzikov AB, Vandenbroucke-Grauls CM, van Kooyk Y, Appelmelk BJ, Geijtenbeek TB.

Immunobiology. 2004;209(1-2):117-27.

PMID:
15481146
8.

Mycobacteria target DC-SIGN to suppress dendritic cell function.

Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, Appelmelk B, Van Kooyk Y.

J Exp Med. 2003 Jan 6;197(1):7-17.

9.

A METHOD OF INTRAVENOUS MEDICATION.

KOPPEL AC, KOPPEL EA.

J Dist Columbia Dent Soc. 1965 Feb;40:11-3 PASSIM. No abstract available.

PMID:
14267239

Supplemental Content

Loading ...
Support Center